• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Use of Bayesian statistics in drug development: Advantages and challenges.贝叶斯统计学在药物研发中的应用:优势与挑战。
Int J Appl Basic Med Res. 2012 Jan;2(1):3-6. doi: 10.4103/2229-516X.96789.
2
Comparison of Bayesian and frequentist group-sequential clinical trial designs.贝叶斯与频率派群组序贯临床试验设计的比较。
BMC Med Res Methodol. 2020 Jan 7;20(1):4. doi: 10.1186/s12874-019-0892-8.
3
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.
4
A Bayesian-frequentist two-stage single-arm phase II clinical trial design.贝叶斯-频率派两阶段单臂二期临床试验设计。
Stat Med. 2012 Aug 30;31(19):2055-67. doi: 10.1002/sim.5330. Epub 2012 Mar 13.
5
Using Bayesian modeling in frequentist adaptive enrichment designs.在频率主义者自适应富集设计中使用贝叶斯建模。
Biostatistics. 2018 Jan 1;19(1):27-41. doi: 10.1093/biostatistics/kxw054.
6
Frequentist operating characteristics of Bayesian optimal designs via simulation.通过模拟的贝叶斯最优设计的频率论操作特征
Stat Med. 2019 Sep 20;38(21):4026-4039. doi: 10.1002/sim.8279. Epub 2019 Jun 19.
7
Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophy.贝叶斯建模和模拟在罕见病药物开发早期决策中的应用:以杜氏肌营养不良症为例。
PLoS One. 2022 Apr 28;17(4):e0247286. doi: 10.1371/journal.pone.0247286. eCollection 2022.
8
Bayesian analysis: a new statistical paradigm for new technology.贝叶斯分析:新技术的一种新统计范式。
Ann Thorac Surg. 2002 Dec;74(6):1901-8. doi: 10.1016/s0003-4975(02)04535-6.
9
Bayesian designs and the control of frequentist characteristics: a practical solution.贝叶斯设计与频率论特征的控制:一种实用解决方案。
Biometrics. 2015 Mar;71(1):218-226. doi: 10.1111/biom.12226. Epub 2014 Sep 5.
10
Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval.用于监管批准的人类细胞和组织产品的贝叶斯统计与临床试验设计。
Regen Ther. 2016 Oct 10;5:86-95. doi: 10.1016/j.reth.2016.09.001. eCollection 2016 Dec.

引用本文的文献

1
Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis.贝叶斯方法在肿瘤学临床试验中的应用:一项横断面分析。
Front Pharmacol. 2025 Mar 25;16:1548997. doi: 10.3389/fphar.2025.1548997. eCollection 2025.
2
Sex as a Biological Variable in Early-Phase Oncology Clinical Trials: Enhancing the Path to Personalised Medicine.早期肿瘤学临床试验中的性别作为生物学变量:推动个性化医疗之路
Heliyon. 2024 Jun 7;10(12):e32597. doi: 10.1016/j.heliyon.2024.e32597. eCollection 2024 Jun 30.
3
Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation.实用随机对照试验:通过强大的国际合作网络加强概念:PRIME-9-通过多国试验进行实用研究和创新。
Trials. 2024 Jan 23;25(1):80. doi: 10.1186/s13063-024-07935-y.
4
A platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism spectrum POC initiative (ASPI).一种用于自闭症谱系障碍概念验证(POC)研究的平台试验方法:自闭症谱系概念验证计划(ASPI)。
Contemp Clin Trials Commun. 2023 Jan 16;32:101061. doi: 10.1016/j.conctc.2023.101061. eCollection 2023 Apr.
5
Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector.人工智能在医疗保健领域的缺点及其潜在解决方案。
Biomed Mater Devices. 2023 Feb 8:1-8. doi: 10.1007/s44174-023-00063-2.
6
Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring.贝叶斯方法的应用:通过万古霉素治疗药物监测将数学建模整合到临床药学中。
Pharmacol Res Perspect. 2022 Dec;10(6):e01026. doi: 10.1002/prp2.1026.
7
Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles.贝叶斯方法在加速罕见病药物研发中的应用:范围和障碍。
Orphanet J Rare Dis. 2022 May 7;17(1):186. doi: 10.1186/s13023-022-02342-5.
8
Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.贝叶斯适应性设计在儿科临床试验中的应用,该设计结合了社区的先验信念。
BMC Med Res Methodol. 2022 Apr 21;22(1):118. doi: 10.1186/s12874-022-01569-x.
9
Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges.贝叶斯方法在罕见病确证性试验中的应用:机遇与挑战。
Int J Environ Res Public Health. 2021 Jan 24;18(3):1022. doi: 10.3390/ijerph18031022.
10
Potential harm caused by physicians' a-priori beliefs in the clinical effectiveness of hydroxychloroquine and its impact on clinical and economic outcome - A simulation approach.羟氯喹临床疗效的先验信念对临床和经济结果的潜在危害——一种模拟方法。
J Crit Care. 2021 Apr;62:138-144. doi: 10.1016/j.jcrc.2020.12.003. Epub 2020 Dec 9.

本文引用的文献

1
Adaptive design clinical trials: Methodology, challenges and prospect.适应性设计临床试验:方法学、挑战与展望。
Indian J Pharmacol. 2010 Aug;42(4):201-7. doi: 10.4103/0253-7613.68417.
2
A Bayesian hierarchical mixture model for platelet derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer.一种用于血小板衍生生长因子受体磷酸化的贝叶斯分层混合模型,以改善前列腺癌无进展生存期的估计。
J R Stat Soc Ser C Appl Stat. 2009 Sep 3;59(1):19-34. doi: 10.1111/j.1467-9876.2009.00680.x.
3
Structural and parameter uncertainty in Bayesian cost-effectiveness models.贝叶斯成本效益模型中的结构和参数不确定性。
J R Stat Soc Ser C Appl Stat. 2010 Mar;59(2):233-253. doi: 10.1111/j.1467-9876.2009.00684.x.
4
Bayesian Model Checking for Multivariate Outcome Data.多元结果数据的贝叶斯模型检验
Comput Stat Data Anal. 2009 Sep 1;53(11):3765-3772. doi: 10.1016/j.csda.2009.03.024.
5
A hierarchical Bayesian design for phase I trials of novel combinations of cancer therapeutic agents.一种用于癌症治疗药物新组合的I期试验的分层贝叶斯设计。
Biometrics. 2010 Sep;66(3):805-12. doi: 10.1111/j.1541-0420.2009.01363.x.
6
Bayesian variable selection using an adaptive powered correlation prior.使用自适应加权相关先验的贝叶斯变量选择
J Stat Plan Inference. 2009 Aug 1;139(8):2665-2674. doi: 10.1016/j.jspi.2008.12.004.
7
Bayesian model selection using test statistics.使用检验统计量的贝叶斯模型选择
J R Stat Soc Series B Stat Methodol. 2008 Oct 14;71(1):143-158. doi: 10.1111/j.1467-9868.2008.00678.x.
8
Bayesian computation and model selection without likelihoods.贝叶斯计算与无似然模型选择。
Genetics. 2010 Jan;184(1):243-52. doi: 10.1534/genetics.109.109058. Epub 2009 Sep 28.
9
Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.德克萨斯大学MD安德森癌症中心的贝叶斯临床试验。
Clin Trials. 2009 Jun;6(3):205-16. doi: 10.1177/1740774509104992.
10
Bayesian versus frequentist statistical inference for investigating a one-off cancer cluster reported to a health department.贝叶斯方法与频率论统计推断在调查上报给卫生部门的一次性癌症聚集性病例中的应用
BMC Med Res Methodol. 2009 May 11;9:30. doi: 10.1186/1471-2288-9-30.

贝叶斯统计学在药物研发中的应用:优势与挑战。

Use of Bayesian statistics in drug development: Advantages and challenges.

作者信息

Gupta Sandeep K

机构信息

Department of Medical Affairs and Clinical Research, Ranbaxy Laboratories Ltd., Gurgaon, Haryana, India.

出版信息

Int J Appl Basic Med Res. 2012 Jan;2(1):3-6. doi: 10.4103/2229-516X.96789.

DOI:10.4103/2229-516X.96789
PMID:23776799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3657986/
Abstract

MAINLY, TWO STATISTICAL METHODOLOGIES ARE APPLICABLE TO THE DESIGN AND ANALYSIS OF CLINICAL TRIALS: frequentist and Bayesian. Most traditional clinical trial designs are based on frequentist statistics. In frequentist statistics prior information is utilized formally only in the design of a clinical trial but not in the analysis of the data. On the other hand, Bayesian statistics provide a formal mathematical method for combining prior information with current information at the design stage, during the conduct of the trial, and at the analysis stage. It is easier to implement adaptive trial designs using Bayesian methods than frequentist methods. The Bayesian approach can also be applied for post-marketing surveillance purposes and in meta-analysis. The basic tenets of good trial design are same for both Bayesian and frequentist trials. It has been recommended that the type of analysis to be used (Bayesian or frequentist) should be chosen beforehand. Switching to an analysis method that produces a more favorable outcome after observing the data is not recommended.

摘要

主要有两种统计方法适用于临床试验的设计和分析

频率学派方法和贝叶斯方法。大多数传统的临床试验设计基于频率学派统计学。在频率学派统计学中,先验信息仅在临床试验设计中正式使用,而不在数据分析中使用。另一方面,贝叶斯统计学提供了一种正式的数学方法,用于在试验设计阶段、试验进行期间以及分析阶段将先验信息与当前信息相结合。使用贝叶斯方法比频率学派方法更容易实施适应性试验设计。贝叶斯方法也可用于上市后监测目的和荟萃分析。贝叶斯试验和频率学派试验的良好试验设计的基本准则是相同的。建议事先选择要使用的分析类型(贝叶斯或频率学派)。不建议在观察数据后切换到能产生更有利结果的分析方法。